Lamivudine, manufactured by SMS Pharmaceuticals Limited, has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

The survey on the updated Post PQ Change Request process and PQDx 121 guidance shows that manufacturers are broadly satisfied with recent improvements to the system.

WHOAPI-429 (tenofovir disoproxil fumarate) manufactured by Styrax Pharma Pvt Ltd has been prequalified by the WHO Prequalification Team medicines under its API prequalification procedure.

A Position Note on Accessories has been published by the Assessment of Medical Devices Team.

New WHO Public Inspection Reports (WHOPIRs) were published today:

On 11 February 2026 WHO published an amended invitation to manufacturers of Monkeypox virus IVDs

New WHO Public Inspection Reports (WHOPIRs) were published today:

This survey aims to gather feedback on the updated PQDx 121 guidance, the new change request submission form, and the overall submission and assessment process.